#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hydrocephalus Iron overload Small cell lung cancer limited stage Adrenoleukodystrophy Prophylaxis against transplant rejection Squamous cell carcinoma of the hypopharynx Squamous cell carcinoma of the oral cavity Multifocal motor neuropathy Chronic myeloid leukaemia (in remission) Liposarcoma recurrent Acromegaly Prostate cancer Astrocytoma malignant Osteomyelitis B-cell small lymphocytic lymphoma refractory More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Basic Information Small intestine leiomyosarcoma – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Toxic epidermal necrolysis – Basic Information Pelizaeus-Merzbacher disease – Treatment Hairy cell leukaemia – Life with Disease Mucous membrane pemphigoid – Basic Information Aicardi-Goutieres syndrome – Life with Disease Leukoencephalopathy – Treatment Pelizaeus-Merzbacher disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Resiquimod Sulfate Clofarabine Atropine Sulfate Mva-209-Fsp-B3 Nicotinamide 18F-Fludarabine Heparin Pentoxifylline Cabotegravir Cart45Ra-Nkg2D Cells Vib1116 Cft1946 VG801-1 Dirocaftor L-Ascorbic Acid Etoposide Phosphate Mecasermin Rinfabate Phosphocreatine Sodium Codeine Phosphate Hemihydrate Indapamide More therapies…

    Learn about Your Condition

    Testicular germ cell cancer Procedural headache Retroperitoneal fibrosis Uterine leiomyosarcoma Ewing's sarcoma metastatic Conjunctivitis allergic Hyperglycaemia Lymphatic malformation Tendon rupture Hypotonia Venous thrombosis Pancreatic neoplasm Primary hyperoxaluria Renal impairment Soft tissue sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mljgan Zwqvoxya Kpxns 2zl Deueodtpp 4sphx Hhljapo

Want to learn more about this study or check if you can participate? Contact us.

  • Evaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Gemcitabine Hydrochloride
    • Paclitaxel
    Belgium Czechia Denmark Finland France Germany +7

  • Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Maridebart Cafraglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +12

  • Study of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    • Azacitidine
    • Venetoclax
    Austria Belgium Czechia Denmark France Germany +6

  • Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Carboplatin
    • Docetaxel
    • Infliximab
    Austria Belgium Denmark Finland France Germany +7

  • Study on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis

    Recruiting

    2 1 1
    Investigated Drugs:
    • Lutikizumab
    • Risankizumab
    Czechia France Hungary Poland

  • Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Cimetidine Hydrochloride
    • Buclizine Hydrochloride
    • Carboplatin
    Austria Belgium Czechia Denmark Finland France +10

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6

  • Study on the Effectiveness and Safety of IMVT-1402 for Adults with Graves’ Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Graves’ disease
    Investigated Drugs:
    • IMEROPRUBART
    Belgium Germany Hungary Italy Poland Spain

  • Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    Austria Bulgaria Czechia France Germany Hungary +4

  • Study comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nvl-655
    • Alectinib Hydrochloride
    Austria Belgium Czechia Denmark France Germany +7
Previous Page
1 … 8 9 10 11 12 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!